Skip to main content

Hiba Abou Assi

Assistant Professor of Medicine
Medicine, Endocrinology, Metabolism, and Nutrition
227 Baker Hse, Box 3924, Durham, NC 27710

Selected Grants


REDEFINE NN9838-4942

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2023 - 2027

Molecular Transducers of Physical Activity and Health: NC Consortium Clinical Site

ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2025

Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) - Microbiome Collection

Clinical TrialCo Investigator · Awarded by The George Washington University · 2012 - 2023

Semaglutide effects on cardiovascular outcomes in people with overweight or obesity

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2019 - 2023

External Relationships


  • Eli Lilly & Co.
  • Gilead Sciences, Inc.
  • MRNA
  • Novo Nordisk
  • Pfizer Inc.
  • Eli Lilly & Co.
  • Gilead Sciences, Inc.
  • MRNA
  • Novo Nordisk
  • Pfizer Inc.
  • Regeneron Pharmaceuticals

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.